Related Experiment Videos
[Hypercholesterolemia-related cardiovascular risk: a continuum from a notion of normality, intervention threshold and
1Département de Médecine, Université de Liège.
Insights
High blood cholesterol presents a continuous cardiovascular risk, complicating treatment goals. Evidence-based medicine must balance cost-effectiveness to target high-risk individuals for effective cardiovascular disease prevention.
Area of Science:
- Cardiovascular Medicine
- Public Health
Context:
- Cardiovascular risk and blood cholesterol levels exist on a continuum.
- Defining normal cholesterol values, intervention thresholds, and therapeutic goals is challenging due to this continuum.
Purpose:
- To address the challenges in defining cholesterol management strategies.
- To reconcile evidence-based medicine with pharmacoeconomic constraints.
Summary:
- Evidence-based medicine highlights the need to focus resources on high-risk populations.
- Pharmacoeconomic factors necessitate prioritizing interventions for individuals with the highest cardiovascular risk.
- Current therapeutic strategies impact a significant portion of the population in industrialized nations.
Impact:
- Informs resource allocation for cardiovascular disease prevention.
- Aids in developing cost-effective strategies for cholesterol management.
- Highlights the broad public health implications of cholesterol management.
Abstract:
There appears to be a continuum between the cardiovascular risk and the level of blood cholesterol, which hinders the definition of normal values, intervention threshold and therapeutic goals. The more and more convincing evidences provided by the "Evidence-Based Medicine" should be confronted to the pharmaco-economical constraints in order to first focus the essential of the efforts and resources on the target population with the highest risk. Unfortunately, the therapeutic strategy concerns a rather high percentage of the population of industrialized countries.